Drug intelligence / Profile preview

S-BAI3

Development stage
Preclinical
Lead developer
University of Alabama at Birmingham
Modality
Recombinant Proteins and Enzymes, Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
01

Overview

S-BAI3 is a novel, short isoform of the adhesion G-protein-coupled receptor BAI3 (encoded by the ADGRB3 gene). It originates from an alternative promoter located in intron 17 of the ADGRB3 gene and is predominantly expressed in the human brain. Unlike the full-length BAI3 (FL-BAI3), which is membrane-bound, S-BAI3 is preferentially localized to intracellular compartments. In glioblastoma multiforme (GBM), S-BAI3 is epigenetically silenced through hypermethylation of its regulatory regions. Research indicates that S-BAI3 acts as a potent tumor suppressor; its overexpression in GBM cell lines significantly reduces proliferation, migration, and invasion. Mechanistically, S-BAI3 reverses the epithelial-to-mesenchymal transition (EMT) signature and promotes a mesenchymal-to-epithelial shift. In vivo studies using orthotopic mouse models have shown that S-BAI3 significantly attenuates tumor growth and confers a survival benefit, making it a potential target for isoform-specific epigenetic reactivation or therapeutic delivery in glioblastoma.

Other names
short BAI3 isoformshort ADGRB3 isoformADGRB3 short isoformADGRB-3 short isoformADGRB 3 short isoform
02

Targets

ADGRB3

Beyond the preview

Go deeper on S-BAI3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-BAI3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call